In France, nearly 10 million patients are prescribed benzodiazepines, a class of sedatives that includes well-known medications like Valium and Xanax, making the country the second-largest consumer of these drugs in Europe. Originally intended for short-term treatment of anxiety and insomnia, the use of these medications has become alarming due to the frequent prolongation of prescriptions without adequate medical supervision. This has contributed to a growing crisis of dependency among the population.

The misuse of benzodiazepines has serious implications for a broad spectrum of patients, ranging from young individuals to the elderly. The lack of proper guidelines and oversight in prescribing practices has created a situation where many patients find themselves trapped in a cycle of reliance on these medications. Experts warn that this trend not only undermines the mental health of individuals but also strains the healthcare system as it grapples with the consequences of widespread addiction.

Olivia Bizot’s report highlights the urgency of addressing this public health issue in France, bringing attention to the need for stricter regulations and better patient education about the risks associated with prolonged use of anti-anxiety medications. As the country navigates its way through this crisis, it must find a balance between providing necessary treatments and preventing the tragedy of addiction that follows these so-called 'miracle pills.'